Medication info

Nesinamet Tablet 12.5/500 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Alogliptin Benzoate›17mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Celltrion Pharm, Inc.
Appearance
Pale yellow, biconvex, rectangular film-coated tablet
Packaging
60 tablets (10 tablets/PTP x 6)
Approval status
Approval withdrawn

MFDS item code 201501047 · Approved 2015.02.27

This product's status changed to Approval withdrawn on 2025.05.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be adjusted according to efficacy and tolerability, without exceeding the maximum recommended daily doses of each component: alogliptin 25mg and metformin 2000mg. The initial dose of this medicine is determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. Patients not currently receiving metformin The initial dose is 1 tablet of this medicine 12.5/500mg twice daily; the dose may be increased to 1 tablet of this medicine 12.5/1000mg twice daily. 2. Patients with inadequate glycemic control on metformin monotherapy The initial dose of this medicine is alogliptin 12.5mg twice daily (total daily dose 25mg) and the patient's current dose of metformin, according to the patient's current treatment regimen. 3. Patients with inadequate glycemic control on combination therapy with metformin and pioglitazone The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. 4. Patients with inadequate glycemic control on combination therapy with metformin and insulin The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. When this medicine is administered concomitantly with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. 5. Substitution for combination therapy with alogliptin and metformin When switching from combination therapy with alogliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of alogliptin and metformin.

Ingredients

Importer
Celltrion Pharm, Inc.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication assists in blood glucose control for patients with type 2 diabetes, supporting dietary and exercise therapy. The combination of alogliptin and metformin effectively improves blood sugar levels to aid in diabetes management. Therefore, this medication is used to improve blood glucose control.

How to take

Adult dose

The dose of this medicine should be adjusted according to efficacy and tolerability, without exceeding the maximum recommended daily doses of each component: alogliptin 25mg and metformin 2000mg. The initial dose of this medicine is determined according to the patient's current treatment regimen. To reduce gastrointestinal adverse reactions associated with metformin use, take this medicine twice daily with meals, and increase the dose gradually. Swallow this medicine whole. 1. Patients not currently receiving metformin The initial dose is 1 tablet of this medicine 12.5/500mg twice daily; the dose may be increased to 1 tablet of this medicine 12.5/1000mg twice daily. 2. Patients with inadequate glycemic control on metformin monotherapy The initial dose of this medicine is alogliptin 12.5mg twice daily (total daily dose 25mg) and the patient's current dose of metformin, according to the patient's current treatment regimen. 3. Patients with inadequate glycemic control on combination therapy with metformin and pioglitazone The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. 4. Patients with inadequate glycemic control on combination therapy with metformin and insulin The initial dose is alogliptin 12.5mg twice daily (total daily dose 25mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. When this medicine is administered concomitantly with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. 5. Substitution for combination therapy with alogliptin and metformin When switching from combination therapy with alogliptin and metformin to this medicine, treatment may be initiated at the patient's current doses of alogliptin and metformin.

Precautions

This medication is a diabetes treatment that contains metformin and alogliptin, which helps in blood glucose control. This medication should not be used in patients with impaired kidney function or severe heart disease. If kidney function is poor, the drug may accumulate in the body and lead to dangerous conditions. It should be used with caution in patients with acute infections, during and after surgery, or those with poor nutritional status, and may be temporarily discontinued if necessary. While taking this medication, lactic acidosis, a serious side effect, can occur rarely, so if symptoms such as fatigue, muscle pain, difficulty breathing, or abdominal pain arise, immediate consultation with a hospital is required. Acute pancreatitis can occur; hence, if severe abdominal pain or vomiting symptoms appear, immediate treatment should be sought. This medication may cause allergic reactions; therefore, if symptoms such as rash, urticaria, or difficulty breathing occur, one should stop taking the medication and visit a hospital immediately. In cases of liver dysfunction, use of this medication should be avoided or approached with caution, and if there are any abnormal symptoms in liver function, immediate consultation with medical personnel is necessary. Regular kidney function tests should be conducted, and if kidney function deteriorates, the medication should be discontinued. Before and after tests using radiographic contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. Excessive alcohol consumption should be avoided while taking this medication, as alcohol can increase the risk of drug side effects. Vitamin B12 levels may decrease; therefore, regular blood tests are advisable, and supplementation therapy should be administered if necessary. If taken in combination with other glucose-lowering agents, symptoms of hypoglycemia may appear, so blood glucose levels must be monitored carefully. In elderly patients, kidney function deterioration is common, hence dosage adjustment and regular kidney function tests are necessary. In cases of overdose, gastrointestinal symptoms or lactic acidosis may occur, so one should visit a healthcare facility immediately for appropriate treatment. This medication is not administered to pregnant or breastfeeding women. Safety in children has not been established, so it is advisable not to use it.

Side effects

  • Upper respiratory tract infection
  • nasopharyngitis
  • diarrhea
  • hypertension
  • headache
  • lumbago
  • urinary tract infection
  • hypoglycemia
  • nausea
  • vomiting
Show 179 more
  • distension
  • asthenia
  • dyspepsia
  • abdominal discomfort
  • pancreatitis
  • anaphylaxis
  • angioedema
  • rash
  • urticaria
  • Stevens-Johnson syndrome
  • serum sickness
  • tendinitis
  • fracture
  • costochondritis
  • leg fracture
  • upper limb fracture
  • spinal fracture
  • rhabdomyolysis
  • gastric ulcer
  • exacerbation of gastritis
  • hemorrhagic gastric ulcer
  • appendicitis
  • hyperglycemia
  • worsening of diabetes
  • abscess
  • infection
  • wound defect
  • thyroid carcinoma
  • lung cancer
  • lung carcinoma
  • chest discomfort
  • generalized edema
  • generalized weakness
  • dyspnea
  • exacerbation of asthma
  • exacerbation of pneumonia
  • respiratory arrest
  • acute renal failure
  • nephrolithiasis
  • renal dysfunction
  • liver cirrhosis
  • cholelithiasis
  • myocardial infarction
  • angina
  • anorexia
  • cerebral infarction
  • transient ischemic attack
  • laceration
  • exacerbation of atrial fibrillation
  • dysphagia
  • stomatitis
  • abdominal pain
  • gastroesophageal reflux disease
  • gastroesophageal reflux
  • gastrointestinal disorder
  • atrophic gastritis
  • non-food-related epigastric pain
  • periodontitis
  • toothache
  • belching
  • anal fissure
  • hematochezia
  • melena
  • constipation
  • nausea
  • vomiting
  • cough
  • increased sputum
  • hemoptysis
  • bronchospasm
  • dry cough
  • chronic obstructive pulmonary disease
  • throat irritation
  • sinusitis
  • shortness of breath
  • tonsillitis
  • vitamin D deficiency
  • increased triglycerides
  • elevated CPK
  • hypertriglyceridemia
  • hyperkalemia
  • acidosis
  • dry eye syndrome
  • gout
  • increased blood sugar levels
  • fever
  • edema
  • fatigue
  • pelvic pain
  • leg edema
  • exacerbation of back pain
  • sacrococcygeal pain
  • pain
  • arm edema
  • exacerbation of chest pain
  • paresthesia
  • sensory disturbances
  • thigh sensory disturbance
  • fecal incontinence
  • tremor
  • numbness
  • neuropathic pain
  • spinal canal stenosis
  • hemiparesis
  • skin sensory disturbance
  • dizziness
  • vertigo
  • lightheadedness
  • ligament injury
  • joint pain
  • fibromyalgia
  • muscle cramps
  • myalgia
  • malaise
  • trigger finger
  • plantar fasciitis
  • tendon rupture
  • arthrosis
  • leg weakness syndrome
  • malaise
  • pruritus
  • contact dermatitis
  • itching
  • keratosis
  • scleroderma
  • increased sweating
  • nail disease
  • otitis externa
  • roseola annulare
  • rosacea
  • contact dermatitis
  • furunculosis
  • seborrheic dermatitis
  • conjunctivitis
  • glaucoma
  • macular degeneration
  • cataract
  • keratitis
  • retinal disease
  • retinal disorder
  • retinal disease
  • cystitis
  • exacerbation of cystitis
  • frequent urination
  • neurogenic bladder
  • kidney cyst
  • urethritis
  • hematuria
  • increased serum creatinine
  • biliary sclerosis
  • fatty liver
  • increased AST
  • increased ALT
  • herpes zoster
  • labial herpes
  • herpes virus infection
  • benign prostatic hyperplasia
  • benign prostatic hyperplasia
  • depression
  • hypersensitivity
  • erectile dysfunction
  • insomnia
  • sleep disorder
  • orthostatic hypotension
  • hypotension
  • tinnitus
  • acute hearing loss
  • Ménière's disease
  • unspecified ear disease
  • coronary artery occlusion
  • exacerbation of angina
  • cataract extraction
  • laceration
  • bradycardia
  • palpitations
  • brain disorder
  • anorexia
  • insomnia
  • itching

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy and safety for a long time.

Appearance and packaging

Appearance

Pale yellow, biconvex, rectangular film-coated tablet

Package unit

60 tablets (10 tablets/PTP x 6)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.